| 标题 |
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Kenneth B. Gordon; Bruce Strober; Mark Lebwohl; Matthias Augustin; Andrew Blauvelt; et al 出版日期:2018-08-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)